Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of Candida albicans

A sparse number of available antifungal drugs, therapeutic side effects, and drug resistance are major challenges in current antifungal therapy to treat Candida albicans-associated infections. Here, we describe two food-derived yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis, that inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunyeit, Lohith, Kurrey, Nawneet K., Anu-Appaiah, K. A., Rao, Reeta P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406282/
https://www.ncbi.nlm.nih.gov/pubmed/34399611
http://dx.doi.org/10.1128/mBio.01891-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406282/
https://www.ncbi.nlm.nih.gov/pubmed/34399611
http://dx.doi.org/10.1128/mBio.01891-21

Ejemplares similares